On February 13, 2026, Nxera Pharma announced Board changes, nominating Mr. Takeo Morooka as new External Director from its Strategic Advisory Council. 2 Ms. Miwa Seki and Mr. Noriaki Nagai will retire from the Board. 2 Appointments subject to approval at the 36th Ordinary General Meeting of Shareholders on March 25, 2026. 2 Mr. Morooka brings expertise in regulatory affairs and pharmaceutical policy from roles like Founder/CEO of PH Consulting and prior Nxera advisory position. 2 Re-appointments include Chris Cargill, David Roblin, Rolf Soderstrom, Naoko Shimura, Nicola Rabson, and Eiko Tomita. 2 Chris Cargill, President & CEO, welcomed Morooka for guidance on growth strategy and thanked outgoing directors. 2 Sources: 2. https://www.globenewswire.com/news-release/2026/02/13/3237936/0/en/Nxera-Pharma-Proposes-Changes-to-its-Board-of-Directors.html
- Get link
- X
- Other Apps